SERA Stock Analysis: Buy, Sell, or Hold?
SERA - Sera Prognostics, Inc. Class A Common Stock
$2.01
-0.01 (-0.50%)
âŧ
5d:
+0.5%
30d:
-6.94%
90d:
+26.42%
WAIT
LOW Confidence
Analysis Updated: Aug 13, 2026 12:00 AM ET
Earnings: Aug 12, 2026
0d
Get Alerted When SERA Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
âšī¸ NEUTRAL: SERA is fairly priced but lacks strong directional signals. Wait for clearer setup or better entry on dips.
âšī¸ NEUTRAL: SERA is fairly priced but lacks strong directional signals. Wait for clearer setup or better entry on dips.
In-depth Analysis How we analyze
Valuation Analysis: SERA is currently trading at $2.01, which is considered slightly low relative to its 30-day fair value range of $1.98 to $2.13.
Technical Outlook: Technically, SERA is showing sideways momentum. Immediate support is located at $1.85, while resistance sits at $2.20.
Market Sentiment: SERA scores 69/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. Wall Street analysts see significant upside, with an average price target of $5.50 (+173.6%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, SERA is showing sideways momentum. Immediate support is located at $1.85, while resistance sits at $2.20.
Market Sentiment: SERA scores 69/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. Wall Street analysts see significant upside, with an average price target of $5.50 (+173.6%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
SLIGHTLY LOW
Historical Trading Range
$1.98 -
$2.13
Company Quality Score
51/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
94.7%
All Signals
- BULLISH: Price oversold vs 30-day range
- BULLISH: Strong technical setup (69/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 173.6% below Wall St target ($5.50)
- WARNING: Composite score 51/100 in the bottom quintile â this cohort historically lags the market
Trading Range Analysis
30-Day Trading Range
$1.98 -
$2.13
Current vs Trading Range
SLIGHTLY LOW
Support & Resistance Levels
Support Level
$1.85
Resistance Level
$2.20
Current Trend
Sideways
Technical data as of
Aug 13, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-3.49
Wall Street Target
$5.50
(+173.6%)
Revenue Growth (YoY)
-63.2%
Share & Embed Analysis
Last updated: August 13, 2026 10:20 PM ET
Data refreshes hourly during market hours. Next update: 11:20 PM
Data refreshes hourly during market hours. Next update: 11:20 PM
đĨ Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is SERA showing a specific setup today?
Insider Activity (6 Months)
0
Buys
15
Sells
Net
INSIDERS SELLING
Recent Transactions
Austin Aerts
SELL
1019 shares
2026-03-11
Zhenya Lindgardt
SELL
2973 shares
2026-03-11
Robert Gardner Harrison
SELL
716 shares
2026-03-11
Top Rated Medical Devices Stocks
Top-rated stocks in Medical Devices by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
BSX
Boston Scientific Corp |
STRONG BUY
34 analysts |
$63 | 33 SELL |
|
SYK
Stryker Corporation |
BUY
32 analysts |
$382 | 50 HOLD |
|
PODD
Insulet Corporation |
STRONG BUY
24 analysts |
$172 | 52 HOLD |
|
DXCM
DexCom Inc |
STRONG BUY
27 analysts |
$93 | 30 SELL |
|
ABT
Abbott Laboratories |
STRONG BUY
27 analysts |
$118 | 34 SELL |
